Nathan Smith
Chief Executive / NeuroScientific Biopharmaceuticals
Rank | Company | # | |
---|---|---|---|
123rd | ![]() |
International Equities Corporation | $2.60m |
124th | ![]() |
Argenica Therapeutics | $2.60m |
125th | ![]() |
NeuroScientific Biopharmaceuticals | $2.21m |
126th | ![]() |
Sprintex | $2.17m |
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
87th | Orange Minerals | 122.09% | 0% |
88th | Predictive Discovery | 119.87% | 34.41% |
89th | NeuroScientific Biopharmaceuticals | 117.33% | -14.48% |
90th | BlinkLab | 116.96% | 0% |
91st | SRG Global | 115.8% | 59.49% |
![]() |
NEWS: Tagged in Board moves July 29, 2025 | 29 Jul 2025 |
![]() |
NEW ROLE: Chief Executive, NeuroScientific Biopharmaceuticals | 29 Jul 2025 |
Access to our data for Nathan Smith is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Nathan Smith is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.